Japan Govt OKs New ALS Drug
The health ministry Tuesday approved the production and sale of a new medicine for amyotrophic lateral sclerosis in Japan, raising hopes among patients. In a doctor-led clinical trial, the drug, mecobalamin, extended the survival period of patients within a year of the onset of ALS by over 500 days, surpassing existing drugs.






